9Yards Capital Management

Growth equity · New York, New York

9Yards Capital Management is a growth equity firm based in New York, New York. Founded in 2018, 9Yards Capital is a growth equity firm based in New York. 92 portfolio companies and 6 recorded rounds are on record.

AUM
$494.0M
Portfolio companies
92
Recorded deals
6
2 in last 12M
Last investment
Feb 2026

9Yards Capital Management key facts

  • 9Yards Capital Management is a growth equity firm based in New York, New York with 92 tracked portfolio companies.
  • Notable positions include Databricks, Anduril Industries, Superhuman.
  • PrivateMarketView records 6 deal participations by 9Yards Capital Management.
  • 9Yards Capital Management’s most recent recorded investment was in Feb 2026, one of 2 in the last 12 months and 4 over two years.
  • The team roster lists 13 people.

About 9Yards Capital Management

Founded in 2018, 9Yards Capital is a growth equity firm based in New York. The firm prefers to invest in growth-stage companies operating in the software, cyber/defense, fintech/insurtech, and supply chain tech sectors. This firm is a Registered Investment Adviser (RIA).

Investment activity

9Yards Capital Management joined 4 recorded rounds in the last two years (1 in the last 12 months). By year: 1 in 2026, 3 in 2025 and 2 in 2021. Across all 6 recorded rounds, 4 were later-stage and 2 were early-stage. 9Yards Capital Management most often invests alongside Andreessen Horowitz (3 shared rounds), Accel (2 shared rounds) and Friends & Family Capital (2 shared rounds). Most recently: Databricks (later-stage round, Feb 2026) and Cambridge Aerospace (Series A, Oct 2025).

9Yards Capital Management portfolio at a glance

92 portfolio companies are on record for 9Yards Capital Management, including Databricks, Anduril Industries and Superhuman.

60 of the 92 carry a recorded valuation and 9 have recorded secondary-market trades, the names a secondary buyer or seller can price.

9Yards Capital Management team

13 people are on record at 9Yards Capital Management: 6 partners, 1 managing partner, 1 principal and 5 others. Senior names include Theo Osborne (Co-Founder), David Fisher (Co-Founder) and Donn Boddie (Investor). 11 of them have a verified direct contact on file.

9Yards Capital Management at the SEC

Form ADV · 2026-03 · CRD 299727
Regulatory AUM
—
Private fund assets
$687.6M
Private funds
31 · 31 private equity
Staff
9
Registered office
NEW YORK, NY
SEC status
Approved

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as 9YARDS CAPITAL MANAGEMENT LP).

Free account
See more of the book
  • ·The top 10 names in the book — of 92 recorded positions
  • ·The 10 latest deals — of 6 rounds
  • ·Watchlist + alerts for 9Yards Capital Management's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

92 companies · priced for members
CompanyValuationRole
Databricks▮▮
Anduril Industries▮▮
Superhuman▮▮
+ 89 more companies · all 92, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

9Yards Capital Management recent deals

6 recorded
Feb 2026DatabricksLater Stage VC▮
Oct 2025Cambridge AerospaceSeries A▮
Aug 2025Cambridge AerospaceEarly Stage VC▮
+ 3 more deals · amounts and lead flags are a member featureUnlock all 6 deals

Membership and data by Private Market View

Team
13 people on record — 11 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about 9Yards Capital Management

What companies does 9Yards Capital Management invest in?
9Yards Capital Management has 92 recorded portfolio companies, including Databricks, Anduril Industries, Superhuman.
What is 9Yards Capital Management's AUM?
9Yards Capital Management manages approximately $494.0M in assets.
Is 9Yards Capital Management actively investing?
9Yards Capital Management's most recent recorded investment was in Feb 2026, with 2 investments in the last 12 months.